Touchstone International Medical Science Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
February 08, 2022
Share
Touchstone International Medical Science Co., Ltd. (SHSE:688013) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 23 per share. The shares purchased will be used for the company's equity incentive plan or employee stock ownership plan. The program will be funded out of the company's own funds. The program will be valid till 12 months.
On June 24, 2022, the company announced that it has adjusted its share repurchase price from not more than CNY 23 per share to not more than CNY 22.80 per share.
Touchstone International Medical Science Co Ltd is a China-based company mainly engaged in research, development, innovation, production and sales of high-end surgical staplers. The Company's products include tubular staplers, endoscopic staplers, linear cutting staplers, purse-string staplers and linear suture staplers. Its products are used in the surgical fields of cardiothoracic surgery, gastrointestinal surgery, hepatobiliary spleen and pancreatic surgery, general surgery and urology. The Company conducts its businesses within the China market and to overseas markets such as Italy, Spain, Austria, Brazil, South Korea, the United Kingdom and Australia.
TOUCHSTONE INTERNATIONAL MEDICAL SCIENCE CO., LTD. 
